Selinexor Tablets

DRUG3 trials

Sponsors

Chengdu Zenitar Biomedical Technology Co., Ltd, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Innovent Biologics (Suzhou) Co. Ltd.

Conditions

Multiple MyelomaRecurrent and Refractory Diffuse Large B-cell LymphomaRelapsed or Refractory Multiple Myeloma

Phase 3

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

RecruitingNCT07011056

Chengdu Zenitar Biomedical Technology Co., LtdRecurrent and Refractory Diffuse Large B-cell Lymphoma

Start: 2025-07-18End: 2029-06-30Target: 390Updated: 2025-09-19

Clinical Study of TQB2934 Injection in Relapsed/Refractory Multiple Myeloma

Not yet recruitingNCT07569757

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Multiple Myeloma

Start: 2026-06-01End: 2030-12-01Target: 260Updated: 2026-05-08

A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003

RecruitingNCT07623798

Innovent Biologics (Suzhou) Co. Ltd.Relapsed or Refractory Multiple Myeloma

Start: 2026-06-11End: 2029-12-31Target: 255Updated: 2026-09-17